Llwytho...
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are important for tumorigenesis has emerged as a potential therapeutic strategy for cancer. PROTACs are heterobifunctional molecules consisting of one ligand for binding to a protein of interest (POI) and another to an E3 ubiqui...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Oncogene |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7319888/ https://ncbi.nlm.nih.gov/pubmed/32475992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1336-y |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|